Image_8_AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis.TIF
Background: Optic neuritis (ON) is a cardinal manifestation of multiple sclerosis (MS), aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease. However, the prevalence of AQP4-IgG seropositivity and MOG-IgG seropositivity in isolated ON is unclear, and studies comparing visual outcomes and optical coherence tomography (OCT)-derived structural retinal measures between MS-ON, AQP4-ON, and MOG-ON eyes are limited by small sample sizes.
Objectives: (1) To assess the prevalence of AQP4-IgG and MOG-IgG seropositivity among patients presenting with isolated ON; (2) to compare visual outcomes and OCT measures between AQP4-ON, MOG-ON, and MS-ON eyes.
Methods: In this systematic review and meta-analysis, a total of 65 eligible studies were identified by PubMed search. Statistical analyses were performed with random effects models.
Results: In adults with isolated ON, AQP4-IgG seroprevalence was 4% in non-Asian and 27% in Asian populations, whereas MOG-IgG seroprevalence was 8 and 20%, respectively. In children, AQP4-IgG seroprevalence was 0.4% in non-Asian and 15% in Asian populations, whereas MOG-IgG seroprevalence was 47 and 31%, respectively. AQP4-ON eyes had lower peri-papillary retinal nerve fiber layer (pRNFL; −11.7 μm, 95% CI: −15.2 to −8.3 μm) and macular ganglion cell + inner plexiform layer (GCIPL; −9.0 μm, 95% CI: −12.5 to −5.4 μm) thicknesses compared with MS-ON eyes. Similarly, pRNFL (−11.2 μm, 95% CI: −21.5 to −0.9 μm) and GCIPL (−6.1 μm, 95% CI: −10.8 to −1.3 μm) thicknesses were lower in MOG-ON compared to MS-ON eyes, but did not differ between AQP4-ON and MOG-ON eyes (pRNFL: −1.9 μm, 95% CI: −9.1 to 5.4 μm; GCIPL: −2.6 μm, 95% CI: −8.9 to 3.8 μm). Visual outcomes were worse in AQP4-ON compared to both MOG-ON (mean logMAR difference: 0.60, 95% CI: 0.39 to 0.81) and MS-ON eyes (mean logMAR difference: 0.68, 95% CI: 0.40 to 0.96) but were similar in MOG-ON and MS-ON eyes (mean logMAR difference: 0.04, 95% CI: −0.05 to 0.14).
Conclusions: AQP4-IgG- and MOG-IgG-associated disease are important diagnostic considerations in adults presenting with isolated ON, especially in Asian populations. Furthermore, MOG-IgG seroprevalence is especially high in pediatric isolated ON, in both non-Asian and Asian populations. Despite a similar severity of GCIPL and pRNFL thinning in AQP4-ON and MOG-ON, AQP4-ON is associated with markedly worse visual outcomes.
History
References
- https://doi.org//10.1016/S1474-4422(13)70259-X
- https://doi.org//10.1038/nrneurol.2014.108
- https://doi.org//10.1038/s41582-018-0112-x
- https://doi.org//10.1186/s12974-018-1144-2
- https://doi.org//10.3389/fneur.2018.00888
- https://doi.org//10.1016/j.ajo.2018.07.020
- https://doi.org//10.1212/WNL.0000000000000101
- https://doi.org//10.1177/1352458519864928
- https://doi.org//10.1002/ana.24617
- https://doi.org//10.1097/WCO.0000000000000315
- https://doi.org//10.1126/science.1957169
- https://doi.org//10.1038/s41433-017-0010-2
- https://doi.org//10.1016/j.jclinepi.2009.06.006
- https://doi.org//10.1001/jama.283.15.2008
- https://doi.org//10.1016/S1474-4422(17)30278-8
- https://doi.org//10.1093/brain/aws098
- https://doi.org//10.1016/S1474-4422(12)70213-2
- https://doi.org//10.1212/WNL.0b013e31828c2f7a
- https://doi.org//10.1214/aoms/1177729756
- https://doi.org//10.1371/journal.pone.0022947
- https://doi.org//10.1186/2049-3258-72-39
- https://doi.org//10.1007/s00415-017-8583-z
- https://doi.org//10.1212/NXI.0000000000000012
- https://doi.org//10.1136/bjophthalmol-2019-314845
- https://doi.org//10.1212/NXI.0000000000000081
- https://doi.org//10.1016/j.jns.2010.07.011
- https://doi.org//10.3341/kjo.2018.0050
- https://doi.org//10.1080/08820538.2016.1208761
- https://doi.org//10.1016/j.jns.2018.11.029
- https://doi.org//10.1136/jnnp-2019-320493
- https://doi.org//10.1001/archneurol.2011.2956
- https://doi.org//10.1177/1352458517734070
- https://doi.org//10.1136/bjophthalmol-2018-312399
- https://doi.org//10.1016/j.jns.2011.08.030
- https://doi.org//10.1001/jamaneurol.2019.2940
- https://doi.org//10.1007/s00415-017-8651-4
- https://doi.org//10.1007/s00415-016-8155-7
- https://doi.org//10.1136/bjophthalmol-2017-310157
- https://doi.org//10.1097/WNO.0000000000000668
- https://doi.org//10.1001/jamaophthalmol.2017.6757
- https://doi.org//10.1016/j.pediatrneurol.2018.03.003
- https://doi.org//10.1111/ene.13315
- https://doi.org//10.1177/1352458513510223
- https://doi.org//10.1212/01.wnl.0000313375.20123.25
- https://doi.org//10.1016/j.ophtha.2018.03.041
- https://doi.org//10.1007/s00415-015-7844-y
- https://doi.org//10.1001/jamaneurol.2014.3602
- https://doi.org//10.1016/j.jneuroim.2016.02.004
- https://doi.org//10.1136/jnnp-2014-310206
- https://doi.org//10.1016/j.jneuroim.2017.10.001
- https://doi.org//10.1111/ene.13753
- https://doi.org//10.1007/s00415-016-8333-7
- https://doi.org//10.1002/ana.24608
- https://doi.org//10.18240/ijo.2018.10.12
- https://doi.org//10.1136/jnnp-2018-318382
- https://doi.org//10.1186/s12974-019-1521-5
- https://doi.org//10.1186/s12974-016-0720-6
- https://doi.org//10.1136/bjophthalmol-2016-309412
- https://doi.org//10.1371/journal.pone.0170847
- https://doi.org//10.1155/2015/832784
- https://doi.org//10.1016/j.jocn.2018.06.052
- https://doi.org//10.1186/s12886-018-0902-3
- https://doi.org//10.1111/dmcn.13757
- https://doi.org//10.18240/ijo.2018.01.16
- https://doi.org//10.1007/s10072-014-1635-6
- https://doi.org//10.1177/1756285616655264
- https://doi.org//10.1016/j.msard.2018.11.026
- https://doi.org//10.1177/1352458515578888
- https://doi.org//10.1016/j.ophtha.2018.06.022
- https://doi.org//10.1177/1352458513519838
- https://doi.org//10.1016/j.ophtha.2019.01.016
- https://doi.org//10.1177/2055217318791196
- https://doi.org//10.1177/2055217318787829
- https://doi.org//10.1016/j.jneuroim.2016.09.007
- https://doi.org//10.1016/j.neuint.2018.10.016
- https://doi.org//10.1212/WNL.0000000000005560
- https://doi.org//10.1016/j.ophtha.2019.04.042
- https://doi.org//10.3389/fneur.2019.01076
- https://doi.org//10.1001/jamaneurol.2013.5857
- https://doi.org//10.1007/s00415-015-7983-1
- https://doi.org//10.1177/1352458515593406
- https://doi.org//10.1212/NXI.0000000000000225
- https://doi.org//10.3988/jcn.2018.14.3.351
- https://doi.org//10.2147/OPTH.S43894
- https://doi.org//10.3892/etm.2018.6273
- https://doi.org//10.2174/1874364101812010247
- https://doi.org//10.1097/WNO.0b013e3181f8a693
- https://doi.org//10.1136/bmjopen-2015-007766
- https://doi.org//10.1155/2014/568254
- https://doi.org//10.3389/fneur.2020.00501
- https://doi.org//10.1177/2055217317730098
- https://doi.org//10.1212/WNL.0000000000001729
- https://doi.org//10.1016/j.jneuroim.2010.11.004
- https://doi.org//10.1177/1352458508102085
- https://doi.org//10.1212/WNL.0000000000006574
- https://doi.org//10.1136/jnnp-2020-323158
- https://doi.org//10.1212/NXI.0000000000000468
- https://doi.org//10.1371/journal.pone.0066151
- https://doi.org//10.1136/jnnp.2008.166207
- https://doi.org//10.1093/brain/awf151
- https://doi.org//10.1111/bpa.12099
- https://doi.org//10.1212/NXI.0000000000000334
- https://doi.org//10.1212/NXI.0000000000000805
- https://doi.org//10.1212/NXI.0000000000000347
- https://doi.org//10.1186/s12974-016-0746-9
- https://doi.org//10.1002/jnr.22437
- https://doi.org//10.1016/0042-6989(83)90063-9
- https://doi.org//10.1146/annurev-vision-091517-034425
- https://doi.org//10.1016/j.ncl.2016.08.012
- https://doi.org//10.1136/jnnp-2015-312601
- https://doi.org//10.1001/jamaneurol.2014.1581
- https://doi.org//10.1212/NXI.0000000000000674